PODD

Insulet Stock Analysis

AI Rating

Fair
  • Quality9/10
  • Growth 0/10
  • Momentum 2/10
Insulet sales and earnings growth
PODD Growth
Low
  • Revenue Y/Y 30.73%
  • EPS Y/Y -41.21%
  • FCF Y/Y 18.13%
Insulet gross and profit margin trends
PODD Profitability
Great
  • Gross margin 71.60%
  • EPS margin 9.10%
  • ROIC 14.60%
Insulet net debt vs free cash flow
PODD Risk
Great
  • Debt / Equity 0.6
  • Debt / FCF 0.7
  • Interest coverage 6.7

Insulet stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Medical Devices stocks ↗